Pharmafile Logo

The Unknown Unknowns

Patient insights are fundamental to ensuring we understand the reality of living with a condition. We need to consciously  challenge our approach and ensure we are unearthing authentic patient insights that change thinking and enhance programmes.

By Vicky O’Connor, Strategic Solutions Director

I have been a patient …. And I imagine a large proportion of you reading this have been too.

During my time as a patient one thing resonated: Although I was involved, it was very much around the edges. Some of them were important edges, I admit, but as THE person experiencing the care and the treatment, I felt I had important insights and experiences to contribute. For me, at that time there wasn’t a clear way to pass my experiences on, but when the opportunity did come up, I ended up presenting a series of curated highlights that I thought people should hear, rather than anything ‘real’.

I felt then and still feel now that patients (and their carers) are an untapped source of interesting…. and do I dare say game changing information. Over the last few years – terminology including ‘patient-centricity’ and the ‘patient voice’ have been used more widely by the pharmaceutical industry. There is a recognition that involving patients is not only commercially astute but is the right thing to do. Patient experience is now being sought not just to ratify an approach but to ensure the right one is developed in the first place.

Regulatory and reimbursement agencies are also starting to allow, if not encourage the patient perspective, with the FDA stating in guidance in 2018 that ‘patient engagement is critical throughout the medical product development process’

Whilst I would agree with the FDA that this increased focus and desire to ingrain the patient view into all areas of work is critical. I think it’s also critical to acknowledge the differences in perspectives and work pragmatically to address them. Patients are commonly viewed in the context of their treatment journey, whilst patients view treatment in the context of their life. We need to consciously challenge our approach to be sure we are unearthing authentic insights based on this broader more holistic position.

- PMLiVE

At Origins Insights, we are committed to listening to patients to understand their experiences. It’s our passion, it’s what we do every day and it’s what we believe in wholeheartedly.

We believe that to be the most effective, we must understand patients on their terms, in their environment, at a time that suits them.  As not all patients and diseases are the same, we approach each project in a bespoke way and invest in immersive and innovative methodologies that enable us to access authentic insights. Our senior in-house team of research directors distil these into actionable insights – insights that are tangible, clear and which can be used across functions and programmes, providing intelligence that re-defines success.

We would love to show you how we can help you make a difference to patient’s lives. Drop us a line at contact@origins-insights.com and let’s arrange time to speak .

- PMLiVE

This content was provided by Bedrock Healthcare Communications

Company Details

 Latest Content from  Bedrock Healthcare Communications 

Imagine More for the reporting of consensus programme outputs

The Bedrock team reflects on the latest published guidance in the development of consensus programmes

The Power of Strong Partnerships

The Bedrock team reflects on what is critical to building strong partnerships.

Thinking creatively about patient involvement in publications

Bedrock's freethinking spirit to reimagine publications is on course to include patients in the full end to end of the publication process.

Agility – The Bedrock Way

The rapid pace of innovation, regulatory systems and consumer behaviour requires real agility by medical communication professionals. Bedrock has the agility to keep up with the pace of change and...

Bedrock Healthcare Communications is proud to accept the PMEA for Agility in Pharma Market Excellence

Recognition for a bold and imaginative approach to an actionable clinical consensus for MS patients.

MIRANDA DINI APPOINTED CHIEF OPERATING OFFICER AT RESONANT GROUP

Two additional leadership moves also strengthen management team

The value medical communications bring to phase 2/3 of drug development

Bedrock’s Head of Strategy, Derek Annan, explains why the development of successful communication requires not only planning, strategy and execution (and measurement), it also needs to be able to respond...

Bedrock expands growing strategy and scientific teams

Award-winning Bedrock Healthcare Communications adds three new starters at an exciting time of growth. Meet our new faces and find out what drew them to Bedrock.

Bedrock Healthcare Communications appoints Louise Adamson as Head of Scientific Services

Louise Adamson joins Bedrock as Head of Scientific Services to drive scientific and strategic excellence and grow and develop the scientific team.

Bedrock’s Accelerated Virtual Consensus Programme for Merck wins at Communiqué Awards

The award recognises outstanding achievement in flexing thinking and processes to ensure success.